Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study

Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study

Abstract Background With advancement in the treatment options of rheumatoid arthritis (RA), optimising the outcomes of difficult-to-treat patients has become increasingly important in clinical practice. In particular, insensitivity to first-line biologic disease-modifying anti-rheumatic drugs (bDMAR...

Celý popis

Podrobná bibliografie
Hlavní autoři: Sae Ochi, Kazuyoshi Saito, Fumitaka Mizoguchi, Shigeaki Kato, Yoshiya Tanaka
Médium: Článek
Jazyk:English
Vydáno: BMC 2020-03-01
Edice:Arthritis Research & Therapy
Témata:
Rheumatoid arthritis
Tumour necrosis factor inhibitors
Insensitivity
On-line přístup:http://link.springer.com/article/10.1186/s13075-020-2122-5

Internet

http://link.springer.com/article/10.1186/s13075-020-2122-5

Podobné jednotky